Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy

BACKGROUND: MEK1 (MAP2K1) and MEK2 (MAP2K2) are closely related dual-specificity protein kinases which function by phosphorylating both serine/threonine and tyrosine residues of their substrates ERK1 and ERK2, controlling fundamental cellular processes that include cell growth and proliferation. To...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Gomez-Millan, J., Pajares, B., Perez-Villa, L., Carnero, A., Alvarez, M., De Luque, V., Rivas, F., Trigo, J. M., Toledo, M. D., Alba, E., Medina, J. A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084350/
https://ncbi.nlm.nih.gov/pubmed/27793200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2869-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items